MedPath

Phase II study of hypofractionated intensity-modulated radiation therapy using image-guided radiation techniques for prostate cancer

Phase 2
Conditions
prostate cancer
Registration Number
JPRN-UMIN000007810
Lead Sponsor
Ministry of Health, Labour and Welfare scientific research Kagami squad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
130
Inclusion Criteria

Not provided

Exclusion Criteria

1) Cancer patients with a duplication of activity 2) Patients with severe or uncontrollable diabetes 3) Serious medical complications (uncontrollable pulmonary disease, heart disease, kidney disease, liver disease) 4) Mental diseases which prevent from registration of this trial 5) History of pelvic radiation therapy 6) History of abdominal or pelvic surgery 7) History of prostate surgery including HIFU 8) History of chemotherapy for prostate cancer 9) Patients with inflammatory bowel disease 10) Patients treated with anticoagulant 11) IPSS >= 20 12) Risk organs are too close to the PTV to keep dose constraints. 13) Patients with metal artifacts in pelvic CT images.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of late morbidity
Secondary Outcome Measures
NameTimeMethod
Incidence of acute morbidity, biochemical failure free survival, clinical progression free survival, overall Survival
© Copyright 2025. All Rights Reserved by MedPath